Modelling primaquine-induced haemolysis in G6PD deficiency
<p>Primaquine is the only drug available to prevent relapse in vivax malaria. The main adverse effect of primaquine is erythrocyte age and dose dependent acute haemolytic anaemia in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd). As testing for G6PDd is often unavailable...
| Autores principales: | , , , , |
|---|---|
| Formato: | Journal article |
| Publicado: |
eLife Sciences Publications
2017
|